Abstract: The studio couch of the subject invention is a seating unit having an end unit with a cushion which may be raised and lowered from a closed position to an open position.

Abstract: A sling manufacturing apparatus for constructing a synthetic sling having a cover and a core, includes a frame defining a longitudinal frame axis, a yarn feeder assembly associated with the frame, a drive roller connected to the frame, a tailstock movably mounted to the frame, an idler roller movably mounted to the tailstock, and an idler actuator secured to the tailstock. The drive roller is drivable to draw yarn from the yarn feeder assembly and the tailstock is movable relative to the frame substantially parallel to the longitudinal frame axis. The idler roller is movable relative to the tailstock parallel to the longitudinal frame axis. The idler actuator is configured to move the idler roller from a loading position spaced a first distance from the tailstock to a tensioned position spaced a second distance from the tailstock, wherein the first distance is greater than the second distance.

Abstract: The studio couch of the subject invention is a seating unit having an end unit with a cushion which may be raised and lowered from a closed position to an open position

Abstract: A sling manufacturing apparatus for constructing a synthetic sling having a cover and a core, includes a frame defining a longitudinal frame axis, a yarn feeder assembly associated with the frame, a drive roller connected to the frame, a tailstock movably mounted to the frame, an idler roller movably mounted to the tailstock, and an idler actuator secured to the tailstock. The drive roller is drivable to draw yarn from the yarn feeder assembly and the tailstock is movable relative to the frame substantially parallel to the longitudinal frame axis. The idler roller is movable relative to the tailstock parallel to the longitudinal frame axis. The idler actuator is configured to move the idler roller from a loading position spaced a first distance from the tailstock to a tensioned position spaced a second distance from the tailstock, wherein the first distance is greater than the second distance.

Abstract: The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.

Abstract: The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.

Abstract: The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.

Abstract: The present invention relates to retroviral constructs that encode novel monoclonal antibodies, novel fusion proteins, and chimeric monoclonal antibodies and to methods of using and producing the same. In particular, the present invention relates to methods of producing a fusion protein comprising a microorganism targeting molecule (e.g., immunoglobulin or innate immune system receptor molecule) and a biocide (e.g., bactericidal enzyme) in transgenic animals (e.g., bovines) and in cell cultures. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., beef carcass processing).

Abstract: The present invention relates to the use of biocide (e.g., bactericidal enzyme) to target pathogens. In particular, the present invention provides biocides for use in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., water purification).

Abstract: The present invention relates to retroviral constructs that encode novel monoclonal antibodies, novel fusion proteins, and chimeric monoclonal antibodies and to methods of using and producing the same. In particular, the present invention relates to methods of producing a fusion protein comprising a microorganism targeting molecule (e.g., immunoglobulin or innate immune system receptor molecule) and a biocide (e.g., bactericidal enzyme) in transgenic animals (e.g., bovines) and in cell cultures. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., beef carcass processing).

Abstract: The present invention relates to the use of biocide (e.g., bactericidal enzyme) to target pathogens. In particular, the present invention provides biocides for use in health care (e.g., human and veterinary), agriculture (e.g., animal and plant production), and food processing (e.g., water purification).